CAMBRIDGE, MA, Obsidian Therapeutics, a clinical-stage biotechnology company pioneering engineered cell and gene therapies, announced it has closed a significantly oversubscribed $160.5 million Series C financing. Read More
CANTON, MA, Conformation-X Therapeutics, announced that it has closed an oversubscribed funding tranche of $3.65M, bringing the total raised since inception to over $13.5M. Read More
ENGLEWOOD, CO, Netgain, a leading software provider for finance and accounting teams, announced a $35 million minority investment led by Summit Partners. Read More